Vaccination hesitancy and the “myth” on mRNA‐based vaccines in Italy in the COVID‐19 era: Does urgency meet major safety criteria?
Salvatore Chirumbolo
Abstract
Coronavirus disease 2019 (COVID-19) vaccination campaign in Italy has started with a huge perplexity about vaccine efficacy, vaccine-borne adverse effects and vaccine clinical trial studies. In this commentary I tried to elucidate these issues, which represent a fundamental topic to be thoroughly addressed in COVID-19 pandemic.
Topics & Concepts
VaccinationPandemicCoronavirus disease 2019 (COVID-19)VirologyMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakPerplexityImmunologyOutbreakDiseaseInfectious disease (medical specialty)Computer scienceArtificial intelligenceLanguage modelPathologySARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyViral Infections and Immunology Research